Journey Medical Corp (DERM)
5.06
-0.09
(-1.75%)
USD |
NASDAQ |
Nov 14, 16:00
5.06
0.00 (0.00%)
After-Hours: 17:18
Journey Medical Enterprise Value: 102.58M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 102.58M |
| November 12, 2024 | 108.80M |
| November 11, 2024 | 111.49M |
| November 08, 2024 | 112.94M |
| November 07, 2024 | 114.19M |
| November 06, 2024 | 108.59M |
| November 05, 2024 | 105.28M |
| November 04, 2024 | 106.10M |
| November 01, 2024 | 123.72M |
| October 31, 2024 | 115.02M |
| October 30, 2024 | 114.50M |
| October 29, 2024 | 114.81M |
| October 28, 2024 | 120.20M |
| October 25, 2024 | 115.22M |
| October 24, 2024 | 108.18M |
| October 23, 2024 | 119.16M |
| October 22, 2024 | 123.31M |
| October 21, 2024 | 126.83M |
| October 18, 2024 | 122.69M |
| October 17, 2024 | 119.58M |
| October 16, 2024 | 126.00M |
| October 15, 2024 | 115.22M |
| October 14, 2024 | 116.88M |
| October 11, 2024 | 116.68M |
| October 10, 2024 | 120.20M |
| Date | Value |
|---|---|
| October 09, 2024 | 119.16M |
| October 08, 2024 | 122.27M |
| October 07, 2024 | 126.21M |
| October 04, 2024 | 131.18M |
| October 03, 2024 | 126.21M |
| October 02, 2024 | 125.80M |
| October 01, 2024 | 116.26M |
| September 30, 2024 | 112.94M |
| September 27, 2024 | 114.40M |
| September 26, 2024 | 109.21M |
| September 25, 2024 | 108.18M |
| September 24, 2024 | 103.62M |
| September 23, 2024 | 102.79M |
| September 20, 2024 | 100.51M |
| September 19, 2024 | 101.13M |
| September 18, 2024 | 101.96M |
| September 17, 2024 | 100.51M |
| September 16, 2024 | 108.38M |
| September 13, 2024 | 102.79M |
| September 12, 2024 | 99.68M |
| September 11, 2024 | 95.12M |
| September 10, 2024 | 94.50M |
| September 09, 2024 | 95.95M |
| September 06, 2024 | 92.84M |
| September 05, 2024 | 93.25M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
5.102M
Minimum
Dec 21 2022
149.47M
Maximum
Nov 12 2021
55.00M
Average
42.32M
Median
Enterprise Value Benchmarks
| Fortress Biotech Inc | -1.023M |
| Heron Therapeutics Inc | 290.40M |
| Checkpoint Therapeutics Inc | 157.56M |
| Avenue Therapeutics Inc | -3.065M |
| Eton Pharmaceuticals Inc | 260.83M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.361M |
| Revenue (Quarterly) | 14.86M |
| Total Expenses (Quarterly) | 17.78M |
| EPS Diluted (Quarterly) | -0.17 |
| Gross Profit Margin (Quarterly) | 55.97% |
| Profit Margin (Quarterly) | -22.63% |
| Earnings Yield | -0.40% |
| Operating Earnings Yield | 2.10% |
| Normalized Earnings Yield | -0.2467 |